Overview

Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.

Status:
Completed

Trial end date:
2013-06-01

Target enrollment:

Participant gender:

Summary

The objective is to assess if low pre-transplantation donor specific T-cell reactive patients measured by Enzyme-linked immunosorbent spot (ELISPOT)assay can be safely managed with Calcineurin inhibitor(CNI)-free Sirolimus(SRL)-based immunosuppression.

Phase:

Phase 4

Details

Lead Sponsor:

Josep M Grinyo

Collaborator:

Carlos III Health Institute

Treatments:

Calcineurin Inhibitors
Immunosuppressive Agents